News
PALI
4.980
-24.55%
-1.620
Analysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)
TipRanks · 1d ago
Looking Into Palisade Bio's Recent Short Interest
Palisade Bio's short percent of float has risen 756.82% since its last report. The company has 27 thousand shares sold short. Short interest is the number of shares that have been sold short but have not yet been covered. Short selling is when a trader sells shares of a company in the hope that the price will fall.
Benzinga · 1d ago
S&P 500 Edges Lower; PacBio Shares Plunge
U.S. Stocks traded mixed toward the end of trading on Tuesday. The Dow traded up 0.02% to 37,741.96 while the NASDAQ fell 0.20%. The S&P 500 fell around 0.3% in trading. Information technology shares rose by 0.4% on Tuesday while real estate shares fell by 1.8%. Euro zone European shares closed lower on Tuesday; Asian markets closed lower.
Benzinga · 1d ago
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Sk Skillsoft Corp. Shares dipped 26.7% to $6.74 on Tuesday. The company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. WiSA Technologies, Inc. Shares jumped 85% after the company announced a licensing agreement with an HDTV/PTV brand.
Benzinga · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
The Nasdaq and the S&P 500 were muted on Tuesday as higher Treasury yields pressured equities. The blue-chip Dow bucked the trend on robust results from health insurance heavyweight UnitedHealth. The Dow Jones Industrial Average was up 0.13% at 37,783.35. UnitedHealth Group's quarterly results beat expectations.
Reuters · 2d ago
Palisade Bio Is Maintained at Buy by Maxim Group
Dow Jones · 2d ago
Maxim Group Maintains Buy on Palisade Bio, Adjusts Price Target To $22.5 (reverse stock split 1:15)
Benzinga · 2d ago
JAGX, BSGM and SXTC among mid-day movers
Seeking Alpha · 2d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Palisade Bio (NASDAQ:PALI) stock increased by 65.1% to $6.87 during Tuesday's regular session. China SXT Pharmaceuticals and Intra-Cellular Therapies were among the gainers. Calidi Biotherapeutics (AMEX:CLDI) shares decreased by 58.5% during the session.
Benzinga · 2d ago
Gold Moves Higher; Morgan Stanley Earnings Top Views
U.S. Stocks traded mixed midway through trading on Tuesday. The Nasdaq Composite fell around 0.2% while the Dow traded up 0.13%. Morgan Stanley reported better-than-expected earnings for its first quarter. Health care shares rose by 0.3% on Tuesday while real estate shares fell by 1.8%. Asian markets closed lower in Asia Pacific markets.
Benzinga · 2d ago
Live Nation Antitrust Probe Rattles LYV Stock. What to Know.
Justice Department is planning to file an antitrust lawsuit against Live Nation Entertainment in the coming weeks. The company is accused of taking part in anticompetitive practices. LYV stock is down 6.8% as a result of the reports. Peraso stock, Jaguar Health stock and Palisade Bio (PALI) are also in the news today.
Investorplace · 2d ago
Why Is Peraso (PRSO) Stock Up 53% Today?
Peraso (NASDAQ:PRSO) stock is up 53% as of Tuesday morning. The semiconductor company announced the adoption of its X710 chipset by Panasonic. More than 52 million shares of PRSO stock have been traded this morning. Shares of Jaguar Health (JAGX), Palisade Bio (PALI) and WiSA Technologies (WISA) are on the rise.
Investorplace · 2d ago
Why Palisade Bio Stock Is Soaring Today
Palisade Bio, Inc. Shares are trending on social media and moving on heavy trading volume Tuesday. The company announced the completion of its analysis of PALI-2108. More than 13.2 million shares have already been traded in the session. Palisade bio says the company is confident in its treatment for ulcerative colitis.
Benzinga · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals
Dow Jones Industrial Average up 0.13% after upbeat results from health insurer UnitedHealth. Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals among top stocks on the move. Higher Treasury yields and conflict in the Middle East keep investors on edge.
Reuters · 2d ago
Why Is Jaguar Health (JAGX) Stock Up 44% Today?
Jaguar Health (NASDAQ:JAGX) stock is up 44.3% as of Tuesday morning. The pharmaceutical company announced a new license for a chemo mouth treatment. The company is looking to treat the side effect of chemotherapy with Gelclair. Palisade Bio (PALI), WiSA Technologies (WISA) and BuzzFeed (BZFD) stock are all up on Tuesday.
Investorplace · 2d ago
Why Is Palisade Bio (PALI) Stock Up 57% Today?
Palisade Bio (NASDAQ:PALI) stock is climbing higher on Tuesday after the company revealed additional data for its ulcerative colitis treatment. The positive data from PALI-2108 has more than 21 million shares changing hands. PALI stock is up 57.3% as of Tuesday morning but is still down 24.4% since the start of the year. Palisade is a stock of WiSA Technologies, BuzzFeed and Fisker stock today. There are more stock market news stories worth diving into on Tuesday.
Investorplace · 2d ago
Palisade Bio Shares Surge 80% After Lab Study Results for Ulcerative Colitis Treatment
Palisade Bio shares were up 80% to $7.52 in recent trading. The stock has dropped 69% over the past 12 months. The company said it received positive results from a study of its potential treatment for ulcerative colitis. Palisade said the study underscored its confidence in the treatment.
Dow Jones · 2d ago
Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics among healthcare movers
Healthcare On the Move: Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics among healthcare movers. S&P 500 Health Care Sector +0.08% to 1617.11. Health Care Equipment & Services among healthcare mover.
Seeking Alpha · 2d ago
Palisade Bio stock rallies nearly 100% on colitis drug analysis
Palisade Bio stock rallies nearly 100% on colitis drug analysis. Company released results from an analysis of its drug candidate PALI-2108 in the treatment of ulcerative colitis. Palisade said the analysis showed efficient conversion of the drug into its active PDE4 inhibitor form.
Seeking Alpha · 2d ago
Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit
The Dow Jones index gained more than 100 points on Tuesday. Bank of America Corp. Reported better-than-expected earnings for first quarter. Health care shares rose by 0.4% on Tuesday; real estate shares fell by 1.7%. Asian markets closed lower; European shares were also lower.
Benzinga · 2d ago
More
Webull provides a variety of real-time PALI stock news. You can receive the latest news about Palisade Bio Inc through multiple platforms. This information may help you make smarter investment decisions.
About PALI
Palisade Bio, Inc. is a biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier. The Company’s approach is founded on the discovery that damage to the intestinal epithelial barrier can result in the leakage of digestive enzymes from the gastrointestinal (GI) tract into the peritoneal cavity, which can damage tissues and promote inflammation, causing a broad array of acute and chronic conditions. Its lead therapeutic candidate, LB1148, is an oral liquid formulation of the well-characterized digestive enzyme inhibitor tranexamic acid (TXA), which is being developed for administration prior to surgeries that are at risk of disrupting the intestinal epithelial barrier. LB1148 is formulated as an aqueous solution for oral (enteral) administration. In addition to TXA, the LB1148 formulation contains polyethylene glycol, carbohydrates, and electrolytes.